期刊文献+

纳米银的抗菌特性及其在医学中的应用 被引量:10

The Antibacterial Property of Silver Nanoparticles and Its Application in Medicine
下载PDF
导出
摘要 纳米银是利用现代纳米技术制造的新一代抗菌材料,因其具有优异的抗菌杀菌活性及在伤口修复方面的积极作用,在医学生物学领域获得了广泛应用。目前已有一些纳米银产品应用于临床,如纳米银抗菌凝胶、纳米银敷料、纳米银心血管支架、纳米银导管、纳米银骨水泥等。近年来的研究表明,纳米银的长效、广谱、强效的抗菌活性源于其对微生物复杂而特异的抗菌机制。尽管纳米银不会使病菌产生耐药性,是人们期望中的理想抗菌材料,但研究人员对其毒性机制依然不甚了解。本文就纳米银的合成、抗菌机制、毒性及在医学中的应用做了简要总结和展望。 Silver nanoparticles, as a new antibacterial material, fabricated by modern nanotechnology, has been applied widely in biomedical field owing to its excellent antibacterial character and wound renovation effects. At present, a variety of silver nanoparticles products are used in clinic, such as silver nanoparticles antimicrobial gel, silver nanoparticles wound dressings, silver nanoparticles cardiovascular stents, silver nanoparticles catheters, silver nanoparticles bone cement and so on. In recent years, studies show that silver nanopartieles' s long-lasting, broad-spectrum, potent antibacterial activity stem result from its complex and specific antibacterial mechanism. Silver nanoparticles is a desired antimicrobial material because of no drugresistance. However, researchers still do not quite understand the toxicological properties of silver nanoparticles. With the widespread application in medicine and daily life, the studies on the toxicity and long-term monitoring of silver nanopartieles must be a cause for concern. This paper makes a brief summary and, outlook on the synthesis, antimicrobial mechanism, toxicity and application in medicine of silver nanoparticles.
出处 《北京生物医学工程》 2011年第2期205-209,共5页 Beijing Biomedical Engineering
基金 国家自然科学基金(30770579) 国家973项目(2007C13936101) 国家863项目(2007AA021901) 中国药品生物制品检定所中青年研究发展基金(2009C4)资助
关键词 纳米银 合成 抗菌特性 毒性 应用现状 silver nanoparticles synthesis antibacterial toxicity application status
  • 相关文献

参考文献36

  • 1Atiyeh BS,Costagliola M,Hayek SN,et al.Effect of silver on burn wound infection control and healing:Review of the literature[J].Burns,2007,33(2):139-148.
  • 2Sladkova M,Vlckova B,Pavel I,et al.Surface-enhanced Raman scattering from a single molecularly bridged silver nanoparticle aggregate[J].Journal of Molecular Structure,2009,924-926:567-570.
  • 3Esteban-Tejeda L,Malpartida F,Esteban-Cubillo A,et al.The antibacterial and antifungal activity of a soda-lime glass containing silver nanoparticles[J].Nanotechnology,2009,20(8):85103.
  • 4Vigneshwaran N,Nachane RP,Balasubramanya RH,et al.A novel one-pot ‘green' synthesis of stable silver nanoparticles using soluble starch[J].Carbohydrate Research,2006,341:2012-2018.
  • 5Xu GN,Qiao XL,Qiu XL,et al.Preparation and characterization of stable monodisperse silver nanoparticles via photoreduction[J].Colloids and Surfaces A:Physicochemical and Engineering Aspects,2008,320:222-226.
  • 6Carlson C,Hussain SM,Schrand AM,et al.Unique cellular interaction of silver nanoparticles:size-dependent generation of reactive oxygen species[J].The journal of physical chemistry,2008,112:13608-13619.
  • 7Tien DC,Tseng KH,Liao CY,et al.Colloidal silver fabrication using the spark discharge system and its antimicrobial effect on Staphylococcus aureus[J].Medical Engineering & Physics,2008,30(8):948-952.
  • 8Shahverdi AR,Minaeian S,Shahverdi HR,et al.Rapid synthesis of silver nanoparticles using culture supernatants of Enterobacteria:a novel biological approach[J].Process Biochemistry,2007,42(5):919-923.
  • 9王刚林,陈海燕.纳米银妇女外用抗菌器生物学评价方法的初探[J].中国医疗器械杂志,2006,30(6):451-452. 被引量:5
  • 10刘焕亮,王慧杰,袭著革.纳米银的抗菌原理及生物安全性研究进展[J].环境与健康杂志,2009,26(8):736-739. 被引量:63

二级参考文献42

共引文献87

同被引文献87

  • 1杨名保,邱书奇,柯朝阳.细菌生物膜及其相关感染的研究进展[J].中华临床医师杂志(电子版),2011,5(9):2675-2676. 被引量:14
  • 2陈炯,韩春茂,林小玮,唐志坚,苏士杰.纳米银敷料在修复Ⅱ度烧伤创面的应用研究[J].中华外科杂志,2006,44(1):50-52. 被引量:88
  • 3张媛媛,孙皎.纳米银作为抗菌材料的生物安全性研究进展[J].中国医疗器械杂志,2007,31(1):36-38. 被引量:45
  • 4Terra X,Palozza P,Fernandez-Larrea J,et al.Procyanidin dimmer B1 and trimer C1 impair inflammatory response signalling in human monocytes[J].Free Radic Res,2011,45(5):611-619.
  • 5Moues CM, Heule F, Hovius SE. A review of topical nega- tive pressure therapy in wound healing: sufficient evi- dence [J]. Am J Sur,201 ! ,201(4) :544-556.
  • 6Gottrup F,Apelqvist J. Present and new techniques and devices in the treatment of DFU: a critical review of Evi- dence [J]. Diabetes Metab Res Rev,2012,28 (Suppll): 64-71.
  • 7Biswas S, Roy S, Banerjee J, et al. Hypoxia inducible mi- cro RNA 210 attenuates keratinocyte proliferation and im- pairs closure in a murine model of ischemic wounds [J] Proc Natl Acad Sci USA,2010, 107(15) :6976-6981.
  • 8高雷.清创术后伤口感染原因探讨[J].中国医药,2009,4(z1):61.
  • 9Dimakakos E, Katsenis K, Kalemikerakis J, et al. Infect- ed venous leg ulcers:management with silver-releasing Foam Dressing [J]. Wounds, 2009,21( 1 ) : 4-8.
  • 10Finley PJ, I-Iuckfeldt RE, Walker KD, et al. Silver dressings improve diabetic wound healing without reducing bioburden [ J 1. Wounds, 2013, 25 (10):293-301.

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部